News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
205,231 Results
Type
Article (20711)
Company Profile (24)
Press Release (184495)
Multimedia
Podcasts (53)
Webinars (2)
Section
Business (50146)
Career Advice (805)
Deals (7951)
Drug Delivery (78)
Drug Development (35013)
Employer Resources (55)
FDA (6395)
Job Trends (4836)
News (96623)
Policy (14665)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (3)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (1)
40 Under 40 (3)
Academia (1261)
Accelerated approval (33)
ADA (9)
Adcomms (24)
Allergies (139)
Alliances (13443)
ALS (85)
Alzheimer's disease (1170)
Antibody-drug conjugate (ADC) (241)
Approvals (6754)
Artificial intelligence (245)
ASCO (100)
Autoimmune disease (147)
Automation (18)
Bankruptcy (87)
Belgium (11)
Best Places to Work (4268)
BIO (17)
Biologics (37)
BIOSECURE Act (8)
Biosimilars (156)
BioSpace Insights (34)
Biotechnology (20)
Bispecific (20)
Bladder cancer (107)
Brain cancer (45)
Breast cancer (291)
Cancer (2565)
Cardiovascular disease (243)
Career advice (694)
Career pathing (25)
CAR-T (140)
CDC (50)
CDMO (82)
Celiac Disease (4)
Cell-line development (1)
Cell therapy (388)
Cervical cancer (22)
Clinical research (30138)
Collaboration (787)
Commercialization (22)
Company closure (3)
Compensation (202)
Complete response letters (40)
COVID-19 (2312)
CRISPR (57)
C-suite (323)
Cystic fibrosis (67)
Data (4479)
Decentralized trials (2)
Denatured (5)
Depression (65)
Dermatology (107)
Diabetes (316)
Diagnostics (1896)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (24)
Drug discovery (154)
Drug pricing (111)
Drug shortages (18)
Duchenne muscular dystrophy (233)
Earnings (19472)
Editorial (43)
Employer branding (6)
Employer resources (59)
ESMO (125)
Events (25189)
Executive appointments (251)
Eye disease (17)
FDA (8431)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (2)
Friedreich's ataxia (16)
Frontotemporal dementia (23)
Funding (679)
Gene editing (102)
Generative AI (30)
Gene therapy (421)
GLP-1 (501)
Government (2608)
Grass and pollen (5)
Guidances (183)
Healthcare (6008)
Hematology (86)
HIV (62)
Huntington's disease (41)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (75)
Immunology and inflammation (144)
Immuno-oncology (49)
Indications (140)
Infectious disease (2638)
Inflammatory bowel disease (71)
Inflation Reduction Act (7)
Influenza (126)
Intellectual property (89)
Interviews (156)
IPO (3620)
IRA (31)
Job creations (733)
Job search strategy (566)
JPM (29)
Kidney cancer (11)
Kidney disease (73)
Labor market (33)
Layoffs (168)
Leadership (26)
Legal (5192)
Licensing (54)
Liver cancer (37)
Longevity (48)
Lung cancer (342)
Lung diease (6)
Lymphoma (209)
Machine learning (16)
Management (20)
Manufacturing (352)
Marketing (20)
MASH (41)
Medical affairs (2)
Medical device (2813)
Medtech (2876)
Melanoma (97)
Mergers & acquisitions (4772)
Metabolic disorders (732)
Middle East (1)
mRNA (181)
Multiple sclerosis (116)
Multispecific (1)
NASH (4)
Netherlands (15)
Neurodegenerative disease (231)
Neuropsychiatric disorders (45)
Neuroscience (1912)
Neurotech (1)
NextGen: Class of 2026 (1934)
Non-profit (1817)
Now hiring (6)
Obesity (336)
Opinion (166)
Ovarian cancer (93)
Pain (84)
Pancreatic cancer (146)
Parkinson's disease (176)
Partnered (12)
Patents (223)
Patient advocacy (7)
Patient recruitment (313)
Patient selection (40)
Peanut (56)
People (11697)
Peptides (17)
Pharmaceutical (6)
Pharmacy benefit managers (12)
Phase 1 (8879)
Phase 2 (12859)
Phase 3 (11047)
Pipeline (5545)
Policy (171)
Postmarket research (1258)
Preclinical (3972)
Press Release (15)
Prostate cancer (117)
Psychedelics (41)
Radioligand (1)
Radiopharmaceuticals (108)
Rare diseases (727)
Real estate (937)
Recruiting (23)
Regenerative medicine (8)
Regulatory (10060)
Reports (28)
Research institute (1063)
Resumes & cover letters (132)
Rett syndrome (41)
RNA editing (7)
RSV (95)
Schizophrenia (65)
Series A (94)
Series B (68)
Service/supplier (1)
Sickle cell disease (67)
Special edition (9)
Spinal muscular atrophy (130)
Sponsored (17)
Startups (919)
Stem cells (5)
Stomach cancer (11)
Substance use disorders (7)
Supply chain (40)
Switzerland (14)
Tariffs (40)
The Weekly (48)
Vaccines (1119)
Venture capital (46)
Weight loss (250)
Wet AMD (7)
Women's health (63)
Worklife (10)
Date
Today (27)
Last 7 days (216)
Last 30 days (1138)
Last 365 days (9224)
2026 (8453)
2025 (9569)
2024 (11061)
2023 (12383)
2022 (17993)
2021 (19460)
2020 (17546)
2019 (13718)
2018 (10258)
2017 (9300)
2016 (9098)
2015 (10316)
2014 (7231)
2013 (5675)
2012 (5761)
2011 (6189)
2010 (5597)
Location
Africa (328)
Alabama (19)
Alaska (1)
Arizona (90)
Arkansas (2)
Asia (12409)
Australia (2516)
California (4583)
Canada (1196)
China (593)
Colorado (178)
Connecticut (215)
Delaware (159)
Europe (36150)
Florida (783)
Georgia (167)
Hawaii (3)
Idaho (11)
Illinois (397)
India (52)
Indiana (354)
Iowa (5)
Japan (324)
Kansas (60)
Kentucky (20)
Louisiana (19)
Maine (34)
Maryland (635)
Massachusetts (3299)
Michigan (82)
Minnesota (154)
Mississippi (2)
Missouri (66)
Montana (8)
Nebraska (5)
Nevada (50)
New Hampshire (18)
New Jersey (1623)
New Mexico (8)
New York (1366)
North Carolina (526)
North Dakota (2)
Northern California (2410)
Ohio (89)
Oklahoma (3)
Oregon (5)
Pennsylvania (1050)
Puerto Rico (3)
Rhode Island (16)
South America (355)
South Carolina (16)
South Dakota (1)
Southern California (1760)
Tennessee (74)
Texas (532)
United States (16674)
Utah (109)
Vermont (1)
Virginia (65)
Washington D.C. (28)
Washington State (380)
Wisconsin (30)
Wyoming (2)
205,231 Results for "fresenius ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events
Patients had adverse events after receiving a Fresenius Kabi medicine that experienced manufacturing deviations.
October 1, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Fresenius Kabi Receives Pharmacy Strategic Programs Excellence Award From Vizient®
September 30, 2026
·
2 min read
Press Releases
Fresenius Medical Care reports third quarter 2026 performance partially offsetting headwinds and narrowing full year outlook
November 3, 2026
·
20 min read
Press Releases
Vizient Expands Supply Assurance for IV Solutions Through Collaboration With Fresenius Kabi
October 6, 2026
·
2 min read
Press Releases
Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026
October 19, 2026
·
6 min read
Press Releases
Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™
October 22, 2026
·
13 min read
Press Releases
Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion
October 1, 2026
·
3 min read
Press Releases
Fresenius Kabi Launches Denosumab Biosimilars in Canada, with the First and Only Ready-to-Use Pre-Filled Syringe Biosimilar for Oncology
November 16, 2026
·
6 min read
Press Releases
Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform
September 29, 2026
·
7 min read
Press Releases
Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership
September 25, 2026
·
4 min read
1 of 20,524
Next